CIH yields 211.04% · PFE yields 6.13%● Live data
📍 CIH pulled ahead of the other in Year 1
Combined, CIH + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CIH + PFE for your $10,000?
China Index Holdings Limited, together with its subsidiaries, operates a real estate information and analytics service platform in China. The company offers promotion services, including number of online and offline themed campaigns, such as industry forums, periodic updates, and online promotions to its customers to promote their brands. It provides listing services comprising commercial property listing and agent services for commercial properties; access and analytics tools, including appraisal and rating, and land modules, based on proprietary database of commercial real estate information; customized research reports; and data monitoring and survey services. The company serves real estate developers, commercial banks and other financial institutions, academic institutions, property managers, brokers, agents, consultants, and other participants in real estate related business. The company was formerly known as Selovo Investments Limited and changed its name to China Index Holdings Limited. China Index Holdings Limited was incorporated in 2007 and is based in Beijing, China.
Full CIH Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.